FDA & COVID: US Clinical Studies & Market Access Discussion - McDermott Skip to main content

FDA & COVID-19: Discussion on Clinical Studies and Market Access in the United States

FDA & COVID-19: Discussion on Clinical Studies and Market Access in the United States

Overview


Anisa Mohanty will be joining France Biotech to discuss legal and regulatory considerations when running clinical trials, managing supply chain risk, the FDA’s engagement strategies and more.

For additional information and to register, click here.

Dig Deeper

Miami, FL / In-person / March 4-5, 2026

HPE Miami 2026

Las Vegas, NV and Virtual / Speaking Engagements / February 11 – 13, 2026

AHLA Winter Institute 2026: Advising Providers and AI in Health Care

Webinar / Speaking Engagements / January 22, 2026

HIPAA Compliance for Medical Device Companies in the AI Age

San Francisco, CA / In-person / January 13, 2026

McDermott Forum at the 2026 J.P. Morgan Healthcare Conference

Las Vegas, NV / In-person / January 7, 2026

CES 2026 | Is Your Health Data Safe?